《公司业绩》中国稀土(00769.HK)半年亏转盈赚1,394万元
中国稀土(00769.HK)公布截至今年6月底止中期业绩,营业额4.39亿元,按年升1%。亏转盈赚1,393.9万元,上年同期蚀1,137.2万元;每股盈利0.6仙。不派息。
来自稀土分部的收入约2.84亿元,和去年同期相若。然而销售数量却比去年同期减少约三成至约500吨。
期内,集团整体录得毛利率约10%,较去年同期的约4%有所改善。
展望下半年,在中美贸易磨擦持续的背景下,中国将坚定推进科技创新,进一步扩大国内市场需求,并有望增加储备,以维护中国稀土在全球的战略地位,为稀土行业长线发展造就有利条件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.